Kopin Corporation Reports Financial Results for the Second Quarter 2025
-
Created strategic partnership with Theon Sensors to gain significant and immediate access to
Europe ,Southeast Asia and NATO growth opportunities - Introduced first phase of optical automation which is expected to increase throughput and quality and reduce costs
- Positive book to bill including new contract wins in helmet mounted display systems and MicroLED Display research orders
- AI-Enabled OLEDoS NeuralDisplay™ achieved prototype milestone with software and hardware improvements
-
Inclusion in
Russell 2000 and 3000 indexes on June 27th, 2025 - Recently Announced Erich Manz as new Chief Financial Officer, effective September 2nd
“The recently announced Theon Sensors, S.A (Theon) investment in Kopin Europe and our global operations is a transformational event for Kopin,” said Michael Murray, CEO of Kopin. “Theon is a global market leading developer and manufacturer of customizable night vision, thermal imaging systems and Electro-Optical ISR systems. Kopin’s exposure to the European and Southeast Asian defense market has been minimal to date. European NATO nations have pledged to make over a trillion dollars of investments in defense. Our relationship with Theon provides Kopin with a tremendous market leading partner, a vertically integrated optical technology developer and provides immediate access into this rapidly growing market while greatly reducing the time to build our European and Southeast Asian presence and revenue. Kopin provides Theon with access to our advanced display technologies, our growing suite of application specific solutions and a trusted US defense integrator.”
Mr. Murray, continued, “Revenue in the second quarter of 2025 was lower than expectations due to order delays related to US government budget process delays and subsequent customer uncertainty. We are now experiencing improved order flow as we have now received several of the orders previously expected and believe further contracts will be issued over the next few months.
“Defense departments in the
Second Quarter Financial Results
Total revenues for the second quarter ended June 28, 2025, were
Cost of Product Revenues for the second quarter of 2025 were
Research and Development expenses (R&D) for the second quarter of 2025 were
Net Loss Attributed to Kopin Corporation for the second quarter of 2025 was
All amounts above are estimates and readers should refer to our Form 10-Q for the quarter ended June 28, 2025, for final disposition as well as important risk factors.
Earnings Call and Webcast
Kopin Corporation management will host the conference call, followed by a question-and-answer session.
Date: Tuesday, August 12, 2025
Time: 8:30 AM Eastern Time (5:30 AM Pacific Time)
International number: 203-518-9843
Conference ID: KOPIN
Webcast: 2Q25 Webcast Link
The Company will also provide a link https://www.kopin.com/investors/ for those who wish to stream the call via webcast. Please call the conference telephone number 5-10 minutes prior to the start time.
A telephonic replay of the conference call will also be available through August 19, 2025.
Toll-free replay number: 844-512-2921
International replay number: 412-317-6671
Replay passcode: 11159803
About Kopin
Kopin Corporation is a leading developer and provider of innovative display and optical technologies sold as critical components and subassemblies for defense, industrial and consumer products. Kopin’s technology portfolio includes ultra-small MicroLED (µLED), Active-Matrix Liquid Crystal displays (AMLCD), Liquid Crystal on Silicon (LCOS) displays and Organic Light Emitting Diode (OLED) displays, a variety of optics, and low-power ASICs. For more information, please visit Kopin’s website at www.kopin.com. Kopin is a trademark of Kopin Corporation.
Forward-Looking Statements
Statements in this press release may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the safe harbor created by such sections. Words such as “expects,” “believes,” “can,” “will,” “estimates,” and variations of such words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. We caution readers not to place undue reliance on any such “forward-looking statements,” which speak only as of the date made, and advise readers that these forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties, estimates, and assumptions by us that are difficult to predict. These forward-looking statements may include statements with respect to our projected increase in demand for our thermal weapons displays; and our belief that there are opportunities for additional follow-on orders and several new customer development orders which we expect to receive soon. Various factors, some of which are beyond our control, could cause actual results to differ materially from those expressed in, or implied by, such forward-looking statements, including without limitation our ability to produce thermal weapons displays in adequate quantities to meet projected demand, the outcome of any litigation and other factors beyond our control. All such forward-looking statements, whether written or oral, and whether made by us or on our behalf, are expressly qualified by these cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release, except as may otherwise be required by the federal securities laws. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations are described in Part I, Item 1A. Risk Factors; Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; and other parts of our Annual Report on Form 10-K, as amended, for the fiscal year ended December 28, 2024, or as updated from time to time our Securities and Exchange Commission filings.
Kopin Corporation |
|||||||||||
Supplemental Information |
|||||||||||
(Unaudited) |
|||||||||||
|
|||||||||||
| Three Months Ended | Six Months Ended | ||||||||||
| June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | ||||||||
| Display Revenues by Category (in millions) | |||||||||||
| Defense | $ |
6.3 |
$ |
10.4 |
$ |
14.7 |
$ |
18.7 |
|||
| Industrial/Enterprise |
|
1.0 |
|
0.6 |
|
1.4 |
|
1.4 |
|||
| Medical |
|
0.2 |
|
- |
|
0.6 |
|
- |
|||
| R&D |
|
0.9 |
|
1.2 |
|
2.2 |
|
2.1 |
|||
| License and Royalties |
|
0.1 |
|
0.1 |
|
0.1 |
|
0.2 |
|||
| Total | $ |
8.5 |
$ |
12.3 |
$ |
19.0 |
$ |
22.4 |
|||
| Stock-Based Compensation Expense | |||||||||||
| Cost of product revenues | $ |
87,000 |
$ |
268,000 |
$ |
226,000 |
$ |
489,000 |
|||
| Research and development |
|
124,000 |
|
117,000 |
|
242,000 |
|
261,000 |
|||
| Selling, general and administrative |
|
537,000 |
|
291,000 |
|
1,054,000 |
|
661,000 |
|||
$ |
748,000 |
$ |
676,000 |
$ |
1,522,000 |
$ |
1,411,000 |
||||
| Other Financial Information | |||||||||||
| Depreciation and amortization | $ |
225,000 |
$ |
137,000 |
$ |
445,000 |
$ |
332,000 |
|||
Kopin Corporation |
|||||||||||||||
Condensed Consolidated Statements of Operations |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
|||||||||||||||
| Three Months Ended | Six Months Ended | ||||||||||||||
| June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | ||||||||||||
| Revenues: | |||||||||||||||
| Net product revenues | $ |
7,498,436 |
|
$ |
11,054,030 |
|
$ |
16,728,321 |
|
$ |
20,079,396 |
|
|||
| Research and development revenues |
|
907,907 |
|
|
1,170,329 |
|
|
2,144,574 |
|
|
2,070,294 |
|
|||
| Other revenues |
|
48,540 |
|
|
112,064 |
|
|
120,480 |
|
|
219,374 |
|
|||
|
8,454,883 |
|
|
12,336,423 |
|
|
18,993,375 |
|
|
22,369,064 |
|
||||
| Expenses: | |||||||||||||||
| Cost of product revenues |
|
7,071,517 |
|
|
8,685,328 |
|
|
14,700,984 |
|
|
17,226,902 |
|
|||
| Research and development |
|
1,945,436 |
|
|
1,839,663 |
|
|
4,061,357 |
|
|
3,940,416 |
|
|||
| Selling, general and administration |
|
4,899,313 |
|
|
7,267,868 |
|
|
9,600,374 |
|
|
14,499,733 |
|
|||
| Litigation damages |
|
- |
|
|
- |
|
|
- |
|
|
24,800,000 |
|
|||
|
13,916,266 |
|
|
17,792,859 |
|
|
28,362,715 |
|
|
60,467,051 |
|
||||
| Loss from operations |
|
(5,461,383 |
) |
|
(5,456,436 |
) |
|
(9,369,340 |
) |
|
(38,097,987 |
) |
|||
| Other income (expense), net |
|
346,750 |
|
|
(465,562 |
) |
|
1,193,174 |
|
|
(372,226 |
) |
|||
| Loss before provision for income taxes |
|
(5,114,633 |
) |
|
(5,921,998 |
) |
|
(8,176,166 |
) |
|
(38,470,213 |
) |
|||
| Tax provision |
|
(52,000 |
) |
|
- |
|
|
(104,000 |
) |
|
- |
|
|||
| Net loss |
|
(5,166,633 |
) |
|
(5,921,998 |
) |
|
(8,280,166 |
) |
|
(38,470,213 |
) |
|||
| Net loss per share: | |||||||||||||||
| Basic | $ |
(0.03 |
) |
$ |
(0.05 |
) |
$ |
(0.05 |
) |
$ |
(0.32 |
) |
|||
| Diluted | $ |
(0.03 |
) |
$ |
(0.05 |
) |
$ |
(0.05 |
) |
$ |
(0.32 |
) |
|||
| Weighted average number of common shares outstanding: | |||||||||||||||
| Basic |
|
166,351,615 |
|
|
121,400,739 |
|
|
166,234,813 |
|
|
120,757,868 |
|
|||
| Diluted |
|
166,351,615 |
|
|
121,400,739 |
|
|
166,234,813 |
|
|
120,757,868 |
|
|||
| Kopin Corporation | |||||
| Condensed Consolidated Balance Sheets | |||||
| (Unaudited) | |||||
|
|||||
| June 28, 2025 | December 28, 2024 | ||||
| ASSETS | |||||
| Current assets: | |||||
| Cash, restricted cash and marketable securities | $ |
27,837,187 |
$ |
36,629,778 |
|
| Accounts receivable, net |
|
9,481,332 |
|
11,850,654 |
|
| Inventory |
|
6,685,225 |
|
6,134,096 |
|
| Contract assets and unbilled receivables |
|
6,840,887 |
|
7,074,020 |
|
| Prepaid and other current assets |
|
1,795,521 |
|
1,153,852 |
|
| Total current assets |
|
52,640,152 |
|
62,842,400 |
|
| Plant and equipment, net |
|
2,684,545 |
|
2,099,708 |
|
| Operating lease right-of-use assets |
|
2,212,679 |
|
2,134,898 |
|
| Equity investments |
|
3,523,632 |
|
3,564,938 |
|
| Other assets |
|
123,822 |
|
123,822 |
|
| Total assets | $ |
61,184,830 |
$ |
70,765,766 |
|
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||
| Current liabilities: | |||||
| Accounts payable | $ |
4,129,863 |
$ |
5,941,470 |
|
| Accrued expenses |
|
2,994,134 |
|
3,095,414 |
|
| Accrued Compensation |
|
40,000 |
|
40,000 |
|
| Deferred tax liabilities |
|
447,498 |
|
414,118 |
|
| Contract liabilities and billings in excess of revenue earned |
|
275,053 |
|
87,752 |
|
| Operating lease liabilities |
|
765,559 |
|
639,642 |
|
| Accrued warranty |
|
2,016,000 |
|
2,557,000 |
|
| Accrued legal expenses |
|
5,961,506 |
|
6,367,900 |
|
| Accrued litigation damages |
|
24,800,000 |
|
24,800,000 |
|
| Total current liabilities |
|
41,429,613 |
|
43,943,296 |
|
| Other long term liabilities |
|
2,279,107 |
|
2,060,932 |
|
| Operating lease liabilities, net of current portion |
|
1,436,276 |
|
1,479,976 |
|
| Total stockholders' equity |
|
16,039,834 |
|
23,281,562 |
|
| Total liabilities and stockholders' equity | $ |
61,184,830 |
$ |
70,765,766 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20250812668370/en/
For Investor Relations
Kopin Corporation
Richard Sneider
Treasurer and Chief Financial Officer
rsneider@kopin.com
MZ Contact
Brian M. Prenoveau, CFA
MZ Group – MZ North America
KOPN@mzgroup.us
+561 489 5315
Source: Kopin Corporation
